Skip to content

6100

by Boston Scientific

6100 is a medical device (FDA Class III; FDA product code LWP, Implantable pulse generator, pacemaker (non-CRT)) made by Boston Scientific, approved under FDA PMA P010012 on 2 May 2002 and listed in FDA GUDID since 24 Sep 2014 (UDI-DI 00802526463556), active as of 22 Oct 2026. 3 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

1 ongoing

Recall on shared PMA P010012; other models may be affected

Documents

PMA P010012

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00802526463556 UDI-DI Date24 Sep 2014ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR from GUDID Approved NumberP010012 Date2 May 2002DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA PMA P010012 decided 2 May 2002 Active
  • FDA GUDID UDI-DI 00802526463556 listed 24 Sep 2014 Listed

Recalls

19 recalls · 1 ongoing · FDA

    • Ongoing Z-1671-2022 FDA Class II initiated 7 Jul 2022 on shared PMA P010012

    There is potential for unanticipated software anomalies to occur when using the Model 2868 Application loaded on the 3120 ZOOM LATITUTDE programmer when communicating with certain Boston Scientific transvenous defibrillators.

  • 3 recalls, same reason

    • Terminated Z-0080-2018 FDA Class II initiated 4 Oct 2017 on shared PMA P010012
    • Terminated Z-0079-2018 FDA Class II initiated 4 Oct 2017 on shared PMA P010012
    • Terminated Z-0081-2018 FDA Class II initiated 4 Oct 2017 on shared PMA P010012

    The devices have an incorrect firmware configuration.

    • Terminated Z-1556-2010 FDA Unclassified (pre-2012) initiated 15 Mar 2010

    Boston Scientific Corporation has stopped shipment and is retrieving unimplanted devices from US hospital shelves of all its implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) after determining that some manufacturing process changes were not submitted for approval to the US Food & Drug Administration.

    • Terminated Z-0609-2010 FDA Unclassified (pre-2012) initiated 1 Dec 2009

    BSC CRM provided important patient management information regarding Boston Scientific COGNIS CRT-Ds and TELIGEN ICDs. Engineering simulations and field reports indicate that in some cases, implanted devices may encounter sufficient mechanical stress to weaken the bond between the header and case when positioned subpectorally. A weakened header bond may alter lead impedance and introduce noise

  • 6 recalls, same reason

    • Terminated Z-1055-2007 FDA Unclassified (pre-2012) initiated 23 Mar 2007 on shared PMA P010012
    • Terminated Z-1049-2007 FDA Unclassified (pre-2012) initiated 23 Mar 2007 on shared PMA P010012
    • Terminated Z-1052-2007 FDA Unclassified (pre-2012) initiated 23 Mar 2007 on shared PMA P010012
    • Terminated Z-1047-2007 FDA Unclassified (pre-2012) initiated 23 Mar 2007 on shared PMA P010012
    • Terminated Z-1053-2007 FDA Unclassified (pre-2012) initiated 23 Mar 2007 on shared PMA P010012
    • Terminated Z-1054-2007 FDA Unclassified (pre-2012) initiated 23 Mar 2007 on shared PMA P010012

    Boston Scientific has recently identified low-voltage capacitors from a former supplier that may be subject to degradation at a low rate of occurrence. These capacitors may cause accelerated battery depletion and may reduce the time between elective replacement indicator (ERI) and end of life (EOL) to less than 3 months.

    • Terminated Z-0047-2008 FDA Unclassified (pre-2012) initiated 16 Mar 2007

    Atypical Charge Time Behavior: 1)-End of Life (EOL) or ERI is displayed during mid-life (typically 24-48 months), even though battery capacity remains available. 2)- Extended ERI charge time limits: Charge times during mid-life may remain below a normal extension of the ERI charge time . ****** Prophylactic replacement of these devices prior to ERI is not recommended. As stated in the Product Upd

    • Terminated Z-1288-06 FDA Unclassified (pre-2012) initiated 15 May 2006 on shared PMA P010012

    Guidant has identified a pattern of premature battery depletion in devices manufactured with a single lot of capacitors from a single supplier. If function of this low voltage capacitor is compromised, the battery may deplete prematurely.

  • 3 recalls, same reason

    • Terminated Z-0825-06 FDA Unclassified (pre-2012) initiated 7 Apr 2006 on shared PMA P010012
    • Terminated Z-0826-06 FDA Unclassified (pre-2012) initiated 7 Apr 2006 on shared PMA P010012
    • Terminated Z-0827-06 FDA Unclassified (pre-2012) initiated 7 Apr 2006 on shared PMA P010012

    77 distributed devices may have a cracked layer of insulation in a flexible hybrid circuit, leading to internal shorting during charging such as during routine capacitor formation or for defibrillation. This would likely render the device non-functional, resulting in no output and/or telemetry communications.

    • Terminated Z-0863-06 FDA Unclassified (pre-2012) initiated 11 Mar 2006 on shared PMA P010012

    Guidant received 39 reports of devices that exhibited lower than expected battery voltage prior to implant; none of these devices were implanted.

    • Terminated Z-0891-06 FDA Unclassified (pre-2012) initiated 30 Sep 2005 on shared PMA P010012

    Devices manufactured with batteries built on April 26 or 27, 2005, by a single operator, may have battery welds that may have been performed at settings outside of typical manufacturing specifications at the supplier.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

21 dated events

  1. Recall initiated FDA recalls Z-1047-2007
  2. Recall initiated FDA recalls Z-1053-2007
  3. Recall initiated FDA recalls Z-1054-2007
  4. Recall initiated FDA recalls Z-0609-2010
  5. Recall initiated FDA recalls Z-1556-2010
  6. Listed FDA GUDID 00802526463556
  7. Recall initiated FDA recalls Z-0080-2018
  8. Recall initiated FDA recalls Z-0079-2018
  9. Recall initiated FDA recalls Z-0081-2018
  10. Recall initiated FDA recalls Z-1671-2022

11 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

GUDID

Generic name
Implantable electrical stimulation lead suture sleeve
Model / reference
6100
Primary DI / UDI-DI
00802526463556
PMA number
FDA product code
LWP
GMDN term
Implantable electrical stimulation lead suture sleeve
Device class
Class III
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code LWP (Implantable pulse generator, pacemaker (non-CRT)).

Other devices from Boston Scientific

See all devices from Boston Scientific →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)